Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zackery P Bulman

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Microbiology Resource Announcements|March 10, 2026
Complete genome sequences of KPC-producing <i>Klebsiella pneumoniae</i> isolates pre- and post-development of meropenem/vaborbactam resistanceEgon A Ozer, Sophie H Nozick, Nidhi Singh, et al.
Infectious Diseases (London, England)|February 15, 2019
Successful cure of daptomycin-non-susceptible, vancomycin-intermediate Staphylococcus aureus prosthetic aortic valve endocarditis directed by synergistic in vitro time-kill studyZarchi E Sumon, Charles S Berenson, John A Sellick, et al.
Antibiotics (Basel, Switzerland)|July 27, 2022
Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant <i>Acinetobacter baumannii</i> with Polymyxin-Based CombinationsMarisol Wences, Elliot R Wolf, Cindy Li, et al.
International Journal of Antimicrobial Agents|September 6, 2024
Ceftazidime/avibactam alone or in combination with an aminoglycoside for treatment of carbapenem-resistant Enterobacterales infections: A retrospective cohort studyZackery P Bulman, Lishan Cao, Brooke N Curry, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2020
Unraveling the Gentamicin Drug Product Complexity Reveals Variation in Microbiological Activities and NephrotoxicityZackery P Bulman, Ryan Cirz, Darin Hildebrandt, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2017
Influence of <i>rhlR</i> and <i>lasR</i> on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with AzithromycinZackery P Bulman, Neang S Ly, Justin R Lenhard, et al.
Diagnostic Microbiology and Infectious Disease|July 4, 2020
A coup d'état by NDM-producing Klebsiella pneumoniae overthrows the major bacterial population during KPC-directed therapyJustin R Lenhard, Amisha P Rana, Eric Wenzler, et al.
NPJ Biofilms and Microbiomes|March 1, 2024
Optimization of an in vitro Pseudomonas aeruginosa Biofilm Model to Examine Antibiotic Pharmacodynamics at the Air-Liquid InterfaceXing Tan, Yanqin Huang, Amisha Rana, et al.
Infection and Drug Resistance|January 27, 2021
Therapeutic Options for Metallo-β-Lactamase-Producing EnterobacteralesXing Tan, Hwan Seung Kim, Kimberly Baugh, et al.
Frontiers in Microbiology|March 25, 2021
<i>In vitro</i> Optimization of Ceftazidime/Avibactam for KPC-Producing <i>Klebsiella pneumoniae</i>Yanqin Huang, Tiffany Wu, Omar Perez, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Microbiology Resource Announcements|March 10, 2026
Complete genome sequences of KPC-producing <i>Klebsiella pneumoniae</i> isolates pre- and post-development of meropenem/vaborbactam resistanceEgon A Ozer, Sophie H Nozick, Nidhi Singh, et al.
Infectious Diseases (London, England)|February 15, 2019
Successful cure of daptomycin-non-susceptible, vancomycin-intermediate Staphylococcus aureus prosthetic aortic valve endocarditis directed by synergistic in vitro time-kill studyZarchi E Sumon, Charles S Berenson, John A Sellick, et al.
Antibiotics (Basel, Switzerland)|July 27, 2022
Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant <i>Acinetobacter baumannii</i> with Polymyxin-Based CombinationsMarisol Wences, Elliot R Wolf, Cindy Li, et al.
International Journal of Antimicrobial Agents|September 6, 2024
Ceftazidime/avibactam alone or in combination with an aminoglycoside for treatment of carbapenem-resistant Enterobacterales infections: A retrospective cohort studyZackery P Bulman, Lishan Cao, Brooke N Curry, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2020
Unraveling the Gentamicin Drug Product Complexity Reveals Variation in Microbiological Activities and NephrotoxicityZackery P Bulman, Ryan Cirz, Darin Hildebrandt, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2017
Influence of <i>rhlR</i> and <i>lasR</i> on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with AzithromycinZackery P Bulman, Neang S Ly, Justin R Lenhard, et al.
Diagnostic Microbiology and Infectious Disease|July 4, 2020
A coup d'état by NDM-producing Klebsiella pneumoniae overthrows the major bacterial population during KPC-directed therapyJustin R Lenhard, Amisha P Rana, Eric Wenzler, et al.
NPJ Biofilms and Microbiomes|March 1, 2024
Optimization of an in vitro Pseudomonas aeruginosa Biofilm Model to Examine Antibiotic Pharmacodynamics at the Air-Liquid InterfaceXing Tan, Yanqin Huang, Amisha Rana, et al.
Infection and Drug Resistance|January 27, 2021
Therapeutic Options for Metallo-β-Lactamase-Producing EnterobacteralesXing Tan, Hwan Seung Kim, Kimberly Baugh, et al.
Frontiers in Microbiology|March 25, 2021
<i>In vitro</i> Optimization of Ceftazidime/Avibactam for KPC-Producing <i>Klebsiella pneumoniae</i>Yanqin Huang, Tiffany Wu, Omar Perez, et al.
Pageof 6